Synthesis of 1-acetyl-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and evaluation of their anticancer activity

References

• Silverman RB. The organic chemistry of drug design and drug action. Burlington: Elsevier Academic Press USA, 2004; pp 298–302.
   Google Scholar
• Singh S, Saxena AK. 2D-QSAR of purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells. Med Chem Res 2008;17:290–296.
   Google Scholar
• Nussbaumer S, Bonnabry P, Veuthey JL, Fleury-Souverain S. Analysis of anticancer drugs: a review. Talanta 2011;85:2265–2289.
   PubMed Web of Science ®Google Scholar
• Gupta SP. Quantitative structure-activity relationship studies on anticancer drugs. Chem Rev 1994;94:1507–1551.
   Web of Science ®Google Scholar
• Galmarini CM, Mackey JR, Dumontet C. Nucleoside analogues: mechanisms of drug resistance and reversal strategies. Leukemia 2001;15:875–890.
   PubMed Web of Science ®Google Scholar
• Shaharyar M, Abdullah MM, Bakht MA, Majeed J. Pyrazoline bearing benzimidazoles: search for anticancer agent. Eur J Med Chem 2010;45:114–119.
   PubMed Web of Science ®Google Scholar
• Kumar S, Bawa S, Drabu S, Kumar R, Gupta H. Biological activities of pyrazoline derivatives–a recent development. Recent Pat Antiinfect Drug Discov 2009;4:154–163.
   PubMedGoogle Scholar
• Rahman A, Siddiqui AA. Pyrazoline derivatives: a worthy insight into the recent advances and potential pharmacological activities. Int J Pharm Sci Drug Res 2010;2:165–175.
   Google Scholar
• Congiu C, Onnis V, Vesci L, Castorina M, Pisano C. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives. Bioorg Med Chem 2010;18:6238–6248.
   PubMed Web of Science ®Google Scholar
• Al-Abdullah ES. Synthesis and anticancer activity of some novel tetralin-6-yl-pyrazoline, 2-thioxopyrimidine, 2-oxopyridine, 2-thioxo-pyridine and 2-iminopyridine derivatives. Molecules 2011;16:3410–3419.
   PubMed Web of Science ®Google Scholar
• Bano S, Javed K, Ahmad S, Rathish IG, Singh S, Alam MS. Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents. Eur J Med Chem 2011;46:5763–5768.
   PubMed Web of Science ®Google Scholar
• Bashir R, Ovais S, Yaseen S, Hamid H, Alam MS, Samim M et al. Synthesis of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide as anticancer and anti-inflammatory agents. Bioorg Med Chem Lett 2011;21:4301–4305.
   PubMed Web of Science ®Google Scholar
• Havrylyuk D, Zimenkovsky B, Vasylenko O, Zaprutko L, Gzella A, Lesyk R. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. Eur J Med Chem 2009;44:1396–1404.
   PubMed Web of Science ®Google Scholar
• Omar MT. Synthesis of 1-(heterocyclic substituted anilino)-9H-thioxanthon-9-ones and their antitumor activity. Arch Pharm Res 1997;20:610–619.
   PubMedGoogle Scholar
• Johnson M, Younglove B, Lee L, LeBlanc R, Holt H Jr, Hills P et al. Design, synthesis, and biological testing of pyrazoline derivatives of combretastatin-A4. Bioorg Med Chem Lett 2007;17:5897–5901.
   PubMed Web of Science ®Google Scholar
• Farghaly A-R. Synthesis of some new indole derivatives containing pyrazoles with potential antitumor activity. ARKIVOC 2010;11:177–187.
   Web of Science ®Google Scholar
• Huang S, Lin R, Yu Y, Lu Y, Connolly PJ, Chiu G et al. Synthesis of 3-(1H-benzimidazol-2-yl)-5-isoquinolin-4-ylpyrazolo[1,2-b]pyridine, a potent cyclin dependent kinase 1 (CDK1) inhibitor. Bioorg Med Chem Lett 2007;17:1243–1245.
   PubMed Web of Science ®Google Scholar
• Zhu GD, Gong J, Gandhi VB, Woods K, Luo Y, Liu X et al. Design and synthesis of pyridine-pyrazolopyridine-based inhibitors of protein kinase B/Akt. Bioorg Med Chem 2007;15:2441–2452.
   PubMed Web of Science ®Google Scholar
• Manna F, Chimenti F, Fioravanti R, Bolasco A, Secci D, Chimenti P et al. Synthesis of some pyrazole derivatives and preliminary investigation of their affinity binding to P-glycoprotein. Bioorg Med Chem Lett 2005;15:4632–4635.
   PubMed Web of Science ®Google Scholar
• Patani GA, LaVoie EJ. Bioisosterism: A Rational Approach in Drug Design. Chem Rev 1996;96:3147–3176.
   PubMed Web of Science ®Google Scholar
• Lima LM, Barreiro EJ. Bioisosterism: a useful strategy for molecular modification and drug design. Curr Med Chem 2005;12:23–49.
   PubMed Web of Science ®Google Scholar
• Al-Obaid AM, Abdel-Hamide SG, El-Kashef HA, Abdel-Aziz AA, El-Azab AS, Al-Khamees HA et al. Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs. Eur J Med Chem 2009;44:2379–2391.
   PubMed Web of Science ®Google Scholar
• Basnet A, Thapa P, Karki R, Choi H, Choi JH, Yun M et al. 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study. Bioorg Med Chem Lett 2010;20:42–47.
   PubMed Web of Science ®Google Scholar
• Barresi V, Condorelli DF, Fortuna CG, Musumarra G, Scirè S. In vitro antitumor activities of 2,6-di-[2-(heteroaryl)vinyl]pyridines and pyridiniums. Bioorg Med Chem 2002;10:2899–2904.
   PubMedGoogle Scholar
• Porter AG, Jänicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999;6:99–104.
   PubMed Web of Science ®Google Scholar
• Khalaf AA, Kabli RA, Zimaity MT, Khalil AM, Kaddah AM, Al-Rifaie HA. N-Derivatisation of some 3-(2-furyl)- and 3-(2-thienyl)-5-aryl-2-pyrazolines. Indian J Chem 1993;32B:1125–1129.
   Google Scholar
• Mossmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Keiser K, Johnson CC, Tipton DA. Cytotoxicity of mineral trioxide aggregate using human periodontal ligament fibroblasts. J Endod 2000;26:288–291.
   PubMed Web of Science ®Google Scholar
• Malíková J, Swaczynová J, Kolár Z, Strnad M. Anticancer and antiproliferative activity of natural brassinosteroids. Phytochemistry 2008;69:418–426.
   PubMed Web of Science ®Google Scholar
• Wang GW, Klein JB, Kang YJ. Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes. J Pharmacol Exp Ther 2001;298:461–468.
   PubMed Web of Science ®Google Scholar
• Cotter TG, Martin SJ. Techniques in apoptosis (A User’s Guide). London: Portland Press UK, 1996; pp 107–120.
   Google Scholar
• Nugraheni M, Santoso U, Wuryastuti H. In vitro antioxidant, antiproliferative and apoptosis effect of Coleus tuberosus L. Afr J Food Sci 2011;5:232–241.
   Google Scholar